Team 1: Endothelial dysfunction & Therapeutic innovation
Christophe Guignabert and Marc Humbert

Group 2: Therapeutic innovations & Bio-artificial lung

Pr Olaf Mercier, Pr Elie Fadel
Pr Olivier Sitbon, Pr Marc Humbert




Registries, management and innovative therapies


Objective 1:

Development and monitoring of a shared National web-based Registry on pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension                                                                                                              

Objective 2:

Development of innovative therapeutic strategies: combination therapies and novel agents